Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00823732 · ClinicalTrials.gov registry record · NA

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

A NA study of Lung Cancer, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
280
Enrollment target
1
Study location

NCT00823732 is a NA study of Lung Cancer that has completed, run by City of Hope Medical Center. The registered enrollment target is 280 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00823732, a NA study of Lung Cancer, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
280 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Palliative care may be more effective than standard care in improving quality of life and symptoms in patients with lung cancer. PURPOSE: This clinical trial is studying the effects of palliative care on quality of life and symptom control in patients with stage IIIB or stage IV non-small cell lung cancer that cannot be removed by surgery.

Conditions Studied

Interventions

  • OTHER medical chart review
  • OTHER questionnaire administration
  • OTHER educational intervention
  • PROCEDURE psychosocial assessment and care
  • PROCEDURE end-of-life treatment/management

Study Locations (1)

California

  • City of Hope Comprehensive Cancer Center - Duarte

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2008-10
Est. Completion 2014-10
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT00823732

The ClinicalTrials.gov registry entry for NCT00823732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (70% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which medical chart review is the first listed.

NCT00823732 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00823732 about?

NCT00823732 is a clinical study titled "Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery". RATIONALE: Palliative care may be more effective than standard care in improving quality of life and symptoms in patients with lung cancer. PURPOSE: This clinical trial is studying the effects of palliative care on quality of life and symptom control in patients with stage IIIB or stage IV non-smal...

What is the current status of trial NCT00823732?

This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2008-10. Estimated completion is 2014-10.

What conditions does trial NCT00823732 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00823732?

The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), educational intervention (OTHER), psychosocial assessment and care (PROCEDURE), end-of-life treatment/management (PROCEDURE).

Who is sponsoring clinical trial NCT00823732?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00823732 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.